Nuvation Bio (NUVB) Acquisitions (2024)
Nuvation Bio (NUVB) posted quarterly Acquisitions of -$1000.0 for Q4 2024.
Nuvation Bio (NUVB) Acquisitions (2024) Analysis & Trends
Nuvation Bio (NUVB) has reported Acquisitions for 1 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Acquisitions changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2025 stood at -$1000.0 (changed 0.0% YoY), while the FY2024 annual figure was $19.9 million, changed N/A from the prior year.
- Acquisitions held at -$1000.0 in Q4 2024 per NUVB's latest filing.
- Across five years, Acquisitions topped out at -$1000.0 in Q4 2024 and bottomed at -$1000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |